HRP20230122T1 - Fekalna mikrobiota za liječenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih stanica - Google Patents
Fekalna mikrobiota za liječenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih stanica Download PDFInfo
- Publication number
- HRP20230122T1 HRP20230122T1 HRP20230122TT HRP20230122T HRP20230122T1 HR P20230122 T1 HRP20230122 T1 HR P20230122T1 HR P20230122T T HRP20230122T T HR P20230122TT HR P20230122 T HRP20230122 T HR P20230122T HR P20230122 T1 HRP20230122 T1 HR P20230122T1
- Authority
- HR
- Croatia
- Prior art keywords
- sample
- fecal microbiota
- use according
- months
- week
- Prior art date
Links
- 241000736262 Microbiota Species 0.000 title claims 10
- 230000002550 fecal effect Effects 0.000 title claims 10
- 210000003958 hematopoietic stem cell Anatomy 0.000 title claims 3
- 238000002054 transplantation Methods 0.000 claims 3
- 230000008014 freezing Effects 0.000 claims 2
- 238000007710 freezing Methods 0.000 claims 2
- 206010066476 Haematological malignancy Diseases 0.000 claims 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 239000004067 bulking agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1750629A FR3062063B1 (fr) | 2017-01-26 | 2017-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| EP18702952.5A EP3573631B1 (fr) | 2017-01-26 | 2018-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| PCT/EP2018/051941 WO2018138251A1 (fr) | 2017-01-26 | 2018-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20230122T1 true HRP20230122T1 (hr) | 2023-03-31 |
Family
ID=59325347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20230122TT HRP20230122T1 (hr) | 2017-01-26 | 2018-01-26 | Fekalna mikrobiota za liječenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih stanica |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20200188450A1 (enExample) |
| EP (1) | EP3573631B1 (enExample) |
| JP (1) | JP7527109B2 (enExample) |
| KR (1) | KR102517287B1 (enExample) |
| CN (1) | CN110520141A (enExample) |
| AU (1) | AU2018212530B2 (enExample) |
| CA (1) | CA3051807C (enExample) |
| DK (1) | DK3573631T3 (enExample) |
| ES (1) | ES2937965T3 (enExample) |
| FI (1) | FI3573631T3 (enExample) |
| FR (1) | FR3062063B1 (enExample) |
| HR (1) | HRP20230122T1 (enExample) |
| HU (1) | HUE061155T2 (enExample) |
| IL (1) | IL268237B (enExample) |
| LT (1) | LT3573631T (enExample) |
| PL (1) | PL3573631T3 (enExample) |
| PT (1) | PT3573631T (enExample) |
| RS (1) | RS63978B1 (enExample) |
| SI (1) | SI3573631T1 (enExample) |
| WO (1) | WO2018138251A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200038506A (ko) * | 2017-08-07 | 2020-04-13 | 핀치 테라퓨틱스, 인코포레이티드 | 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법 |
| US20220023419A1 (en) * | 2018-11-28 | 2022-01-27 | The Council Of The Queensland Institute Of Medical Research | Inhibiting inflammation |
| CN112375705A (zh) * | 2020-11-12 | 2021-02-19 | 安徽燕婉健康科技有限公司 | 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用 |
| EP4386090A1 (en) * | 2022-12-12 | 2024-06-19 | Assistance Publique - Hôpitaux De Paris | Method for determining and improving the potential efficacy of anticancer treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2649719B1 (fr) * | 1989-07-17 | 1993-08-27 | Cerbio Sa | Procede de protection et de conservation de micro-organismes notamment de bacteries |
| BR112013022927A2 (pt) * | 2011-03-09 | 2016-12-06 | Univ Minnesota | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição |
| CN104918624A (zh) * | 2012-11-26 | 2015-09-16 | 托马斯·朱利叶斯·波洛迪 | 恢复排泄物微生物群的组合物及其制造和使用方法 |
| WO2016057671A1 (en) * | 2014-10-07 | 2016-04-14 | University Of Virginia Patent Foundation | Compositions and methods for preventing and treating infection |
| ES3010296T3 (en) * | 2014-11-25 | 2025-04-02 | Memorial Sloan Kettering Cancer Center | Intestinal microbiota and gvhd |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| FR3035328B1 (fr) * | 2015-04-24 | 2019-08-23 | Maat Pharma | Procede de preparation d'un echantillon de microbiote fecal |
| US20180185421A1 (en) * | 2016-08-29 | 2018-07-05 | Tokyo Metropolitan Government | Composition comprising fecal microbiota |
-
2017
- 2017-01-26 FR FR1750629A patent/FR3062063B1/fr not_active Expired - Fee Related
-
2018
- 2018-01-26 IL IL268237A patent/IL268237B/en unknown
- 2018-01-26 DK DK18702952.5T patent/DK3573631T3/da active
- 2018-01-26 PL PL18702952.5T patent/PL3573631T3/pl unknown
- 2018-01-26 AU AU2018212530A patent/AU2018212530B2/en active Active
- 2018-01-26 HU HUE18702952A patent/HUE061155T2/hu unknown
- 2018-01-26 SI SI201830842T patent/SI3573631T1/sl unknown
- 2018-01-26 CA CA3051807A patent/CA3051807C/fr active Active
- 2018-01-26 JP JP2019540408A patent/JP7527109B2/ja active Active
- 2018-01-26 FI FIEP18702952.5T patent/FI3573631T3/fi active
- 2018-01-26 EP EP18702952.5A patent/EP3573631B1/fr active Active
- 2018-01-26 LT LTEPPCT/EP2018/051941T patent/LT3573631T/lt unknown
- 2018-01-26 PT PT187029525T patent/PT3573631T/pt unknown
- 2018-01-26 WO PCT/EP2018/051941 patent/WO2018138251A1/fr not_active Ceased
- 2018-01-26 RS RS20230101A patent/RS63978B1/sr unknown
- 2018-01-26 HR HRP20230122TT patent/HRP20230122T1/hr unknown
- 2018-01-26 ES ES18702952T patent/ES2937965T3/es active Active
- 2018-01-26 CN CN201880008477.0A patent/CN110520141A/zh active Pending
- 2018-01-26 US US16/480,863 patent/US20200188450A1/en not_active Abandoned
- 2018-01-26 KR KR1020197024970A patent/KR102517287B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102517287B1 (ko) | 2023-03-31 |
| PL3573631T3 (pl) | 2023-05-02 |
| RS63978B1 (sr) | 2023-03-31 |
| IL268237A (en) | 2019-09-26 |
| AU2018212530A1 (en) | 2019-09-05 |
| EP3573631A1 (fr) | 2019-12-04 |
| SI3573631T1 (sl) | 2023-09-29 |
| US20200188450A1 (en) | 2020-06-18 |
| AU2018212530B2 (en) | 2022-06-23 |
| CN110520141A (zh) | 2019-11-29 |
| PT3573631T (pt) | 2023-01-24 |
| ES2937965T3 (es) | 2023-04-03 |
| FR3062063B1 (fr) | 2019-04-19 |
| CA3051807A1 (fr) | 2018-08-02 |
| FI3573631T3 (fi) | 2023-03-02 |
| JP7527109B2 (ja) | 2024-08-02 |
| KR20190130563A (ko) | 2019-11-22 |
| FR3062063A1 (fr) | 2018-07-27 |
| HUE061155T2 (hu) | 2023-05-28 |
| JP2020506183A (ja) | 2020-02-27 |
| WO2018138251A1 (fr) | 2018-08-02 |
| CA3051807C (fr) | 2023-07-11 |
| IL268237B (en) | 2022-07-01 |
| EP3573631B1 (fr) | 2022-11-16 |
| LT3573631T (lt) | 2023-03-10 |
| DK3573631T3 (da) | 2023-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2887583C (fr) | Procede pour conserver le sang placentaire | |
| Gaia et al. | Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease | |
| ES2660211T3 (es) | Medios para la regeneración hepática | |
| ES2827250T3 (es) | Mejora de órganos para trasplante | |
| BR112013004917A2 (pt) | terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais. | |
| JP2014527821A5 (enExample) | ||
| EP2397142A3 (en) | Use of dpp iv inhibitors | |
| CN104430303B (zh) | 人外周血干细胞冻存液的配制及使用方法 | |
| SG195252A1 (en) | Methods and uses for ex vivo tissue culture systems | |
| WO2010082787A3 (ko) | 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물 | |
| CN106237313A (zh) | 一种脐带间充质干细胞注射液及其制备方法和应用 | |
| Qiang et al. | Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs | |
| Zhang et al. | Comparative study on protective effect of hydrogen rich saline and adipose-derived stem cells on hepatic ischemia-reperfusion and hepatectomy injury in swine | |
| CN103610778B (zh) | 抗鸡热应激的中药制剂及其制备方法 | |
| US20160074437A1 (en) | Immunological treatment of liver failure | |
| ES2937965T3 (es) | Microbiota fecal para el tratamiento de pacientes con trasplante de células madre hematopoyéticas | |
| CN109997844A (zh) | 灵芝多糖在家畜精液冷冻长期保存中的应用 | |
| JP2020506183A5 (enExample) | ||
| CN112472810A (zh) | 一种粪菌冻干保护剂及其在粪菌移植中的应用 | |
| Zhang et al. | Adipose-derived mesenchymal stem cells suppress of acute rejection in small bowel transplantation | |
| Wang et al. | Nonexcretion of serum alkaline phosphatase by the liver and the pancreas of normal dogs | |
| JP2012533519A5 (enExample) | ||
| CN117084234A (zh) | 间充质干细胞储存液 | |
| Abdelrahman et al. | Comparative clinicopathological study on the impact of intrauterine infusion of eugenol versus ceftiofur on experimentally induced endometritis in Baladi female goats | |
| CN116965403B (zh) | 一种干细胞保存液及其制备方法和应用 |